# A Study of SYH2051 Monotherapy in Advanced Solid Tumors or in Combination With Radiotherapy in Locally Advanced Head and Neck Cancer

> **NCT06011291** · PHASE1 · UNKNOWN · sponsor: **CSPC ZhongQi Pharmaceutical Technology Co., Ltd.** · enrollment: 73 (estimated)

## Conditions studied

- Solid Tumors
- Head and Neck Cancer

## Interventions

- **DRUG:** SYH2051 tablets
- **RADIATION:** Intensity-Modulated Radiation Therapy (IMRT)

## Key facts

- **NCT ID:** NCT06011291
- **Lead sponsor:** CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08-15
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-08-31
- **Target enrollment:** 73 (ESTIMATED)
- **Last updated:** 2023-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06011291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06011291, "A Study of SYH2051 Monotherapy in Advanced Solid Tumors or in Combination With Radiotherapy in Locally Advanced Head and Neck Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06011291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*